RU / EN
About us
Developing and producing kits for molecular genetic testing
About us
Technologies in next-generation molecular genetics

News and events

15.06.2022
The researchers at TestGene have developed the “SARS-CoV-2-OMICRON” test system
02.04.2022
The TestGene company has received a medical device registration certificate for the “HEPA-C-test-Q” kit for quantitative detection of the hepatitis C virus RNA
30.03.2022
The TestGene company has received a Registration certificate for the kit for qualitative detection of specific regions of the genomic DNA of the hepatitis B virus and RNA of the hepatitis C and D viruses
10.03.2022
The TestGene company has received a Registration certificate for the “COV-2-COLOR-TEST” kit for diagnostics of the SARS-COV-2 coronavirus infection by loop-mediated isothermal amplification (LAMP)
28.02.2022
On January 28, TestGene received the main award in the “Entrepreneur of the year” contest.
22.02.2022
The TestGene company has received a Registration certificate for the kits for screening hereditary tumor syndromes, determination of the strategy and effectiveness of treatment: "HRR-screening" and "BRCA1,2-diagnostics"
10.02.2022
The kit "CoV-2-dif-O" for qualitative detection of the SARS-CoV-2 coronavirus RNA with differentiation of the B.1.1.529 "Omicron" strain by real-time PCR has been registered
08.10.2019
Practical Significance of Prosta-Test Diagnostic Kit for Early Detection of Prostate Cancer was Acknowledged at the International Congress
25.09.2019
TestGene, LLC is a participant of Medica 2019, World Forum for Medicine, Dusseldorf, Germany, 18-21 November
06.02.2017
TestGene has obtained ISO 13485:2003 and EN ISO 13485:2012 Certificates
03.11.2015
TestGene has obtained ISO 9001:2008 Certificate
20.08.2015
During a year GeNext team had been conducting clinical trials of a new prostate cancer testing based on urine methodology.
17.04.2015
Eurasian Patent
09.04.2014
Dmitry Medvedev's visit

Our strategic partners